Persistent expression of the tumor suppressor gene DCC is essential for neuronal differentiation

Cell Growth Differ. 1992 Sep;3(9):609-16.

Abstract

Cell differentiation is associated either with a complete loss of proliferative potential or with a change in growth requirements. Neoplastic transformation may result from the activation of oncogenes that support growth or from inactivation or loss of tumor suppressor genes, which are thought to regulate differentiation. To examine the relationship between tumor suppressor genes and cell differentiation, we chose the gene "deleted in colorectal cancer" (DCC) and studied its role in a pheochromocytoma cell line, PC-12, using antisense RNA as well as antisense oligonucleotides to DCC. When exposed to nerve growth factor for several days, PC-12 cells develop long dendrites. This morphological change follows the transient expression of immediate early genes and is associated with an up-regulation of DCC. Interestingly, if the up-regulation of DCC was counteracted using an antisense RNA technique, the morphological changes were prevented, but the other parameters of the nerve growth factor response were unaffected. Moreover, when DCC expression was inhibited by antisense oligonucleotides to DCC in nerve growth factor-differentiated cells, the neuron-like phenotype was reversed. Our results demonstrate that the gene DCC is involved in a distal segment of neural differentiation and provide the first direct evidence that a tumor suppressor gene plays a role in cell differentiation.

MeSH terms

  • Animals
  • Base Sequence
  • Cell Cycle
  • Cell Differentiation* / drug effects
  • Gene Expression
  • Genes, DCC*
  • In Vitro Techniques
  • Molecular Sequence Data
  • Nerve Growth Factors / pharmacology
  • Neurons / physiology*
  • Oligodeoxyribonucleotides / chemistry
  • Oligonucleotides, Antisense
  • PC12 Cells

Substances

  • Nerve Growth Factors
  • Oligodeoxyribonucleotides
  • Oligonucleotides, Antisense